Trieu Vuong - Nov 22, 2022 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
Nov 22, 2022
Transactions value $
$5,600
Form type
4
Date filed
11/25/2022, 08:00 AM
Previous filing
Sep 28, 2022
Next filing
Dec 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $5.6K +70K +0.08% $0.08 90.4M Nov 22, 2022 Direct
holding OTLC Common Stock 16.8M Nov 22, 2022 By Autotelic, Inc.
holding OTLC Common Stock 6.87M Nov 22, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 70,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on November 22, 2022 from the open market at a price of $0.08.